225 related articles for article (PubMed ID: 21746858)
1. Identification of a novel virulence factor in Clostridium difficile that modulates toxin sensitivity of cultured epithelial cells.
Miura M; Kato H; Matsushita O
Infect Immun; 2011 Sep; 79(9):3810-20. PubMed ID: 21746858
[TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile Toxin Biology.
Aktories K; Schwan C; Jank T
Annu Rev Microbiol; 2017 Sep; 71():281-307. PubMed ID: 28657883
[TBL] [Abstract][Full Text] [Related]
3. Human intestinal enteroids as a model of
Engevik MA; Danhof HA; Chang-Graham AL; Spinler JK; Engevik KA; Herrmann B; Endres BT; Garey KW; Hyser JM; Britton RA; Versalovic J
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G870-G888. PubMed ID: 32223302
[No Abstract] [Full Text] [Related]
4. Toxin B is essential for virulence of Clostridium difficile.
Lyras D; O'Connor JR; Howarth PM; Sambol SP; Carter GP; Phumoonna T; Poon R; Adams V; Vedantam G; Johnson S; Gerding DN; Rood JI
Nature; 2009 Apr; 458(7242):1176-9. PubMed ID: 19252482
[TBL] [Abstract][Full Text] [Related]
5. Toward a structural understanding of Clostridium difficile toxins A and B.
Pruitt RN; Lacy DB
Front Cell Infect Microbiol; 2012; 2():28. PubMed ID: 22919620
[TBL] [Abstract][Full Text] [Related]
6. The Importance of Therapeutically Targeting the Binary Toxin from
Abeyawardhane DL; Godoy-Ruiz R; Adipietro KA; Varney KM; Rustandi RR; Pozharski E; Weber DJ
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805767
[TBL] [Abstract][Full Text] [Related]
7. Tolevamer, an anionic polymer, neutralizes toxins produced by the BI/027 strains of Clostridium difficile.
Hinkson PL; Dinardo C; DeCiero D; Klinger JD; Barker RH
Antimicrob Agents Chemother; 2008 Jun; 52(6):2190-5. PubMed ID: 18391047
[TBL] [Abstract][Full Text] [Related]
8. Difference in F-actin depolymerization induced by toxin B from the Clostridium difficile strain VPI 10463 and toxin B from the variant Clostridium difficile serotype F strain 1470.
May M; Wang T; Müller M; Genth H
Toxins (Basel); 2013 Jan; 5(1):106-19. PubMed ID: 23344455
[TBL] [Abstract][Full Text] [Related]
9. Both, toxin A and toxin B, are important in Clostridium difficile infection.
Kuehne SA; Cartman ST; Minton NP
Gut Microbes; 2011; 2(4):252-5. PubMed ID: 21804353
[TBL] [Abstract][Full Text] [Related]
10. Identification of an epithelial cell receptor responsible for Clostridium difficile TcdB-induced cytotoxicity.
LaFrance ME; Farrow MA; Chandrasekaran R; Sheng J; Rubin DH; Lacy DB
Proc Natl Acad Sci U S A; 2015 Jun; 112(22):7073-8. PubMed ID: 26038560
[TBL] [Abstract][Full Text] [Related]
11. Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease.
Sambol SP; Merrigan MM; Lyerly D; Gerding DN; Johnson S
Infect Immun; 2000 Oct; 68(10):5480-7. PubMed ID: 10992443
[TBL] [Abstract][Full Text] [Related]
12. Membrane translocation of binary actin-ADP-ribosylating toxins from Clostridium difficile and Clostridium perfringens is facilitated by cyclophilin A and Hsp90.
Kaiser E; Kroll C; Ernst K; Schwan C; Popoff M; Fischer G; Buchner J; Aktories K; Barth H
Infect Immun; 2011 Oct; 79(10):3913-21. PubMed ID: 21768281
[TBL] [Abstract][Full Text] [Related]
13. The role of toxin A and toxin B in the virulence of Clostridium difficile.
Carter GP; Rood JI; Lyras D
Trends Microbiol; 2012 Jan; 20(1):21-9. PubMed ID: 22154163
[TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile toxin CDT hijacks microtubule organization and reroutes vesicle traffic to increase pathogen adherence.
Schwan C; Kruppke AS; Nölke T; Schumacher L; Koch-Nolte F; Kudryashev M; Stahlberg H; Aktories K
Proc Natl Acad Sci U S A; 2014 Feb; 111(6):2313-8. PubMed ID: 24469807
[TBL] [Abstract][Full Text] [Related]
15. Binding and neutralization of C. difficile toxins A and B by purified clinoptilolite-tuff.
Ranftler C; Nagl D; Sparer A; Röhrich A; Freissmuth M; El-Kasaby A; Nasrollahi Shirazi S; Koban F; Tschegg C; Nizet S
PLoS One; 2021; 16(5):e0252211. PubMed ID: 34043688
[TBL] [Abstract][Full Text] [Related]
16. A leaky human colon model reveals uncoupled apical/basal cytotoxicity in early
Ok MT; Liu J; Bliton RJ; Hinesley CM; San Pedro EET; Breau KA; Gomez-Martinez I; Burclaff J; Magness ST
Am J Physiol Gastrointest Liver Physiol; 2023 Apr; 324(4):G262-G280. PubMed ID: 36749911
[No Abstract] [Full Text] [Related]
17. Essential role of toxin A in C. difficile 027 and reference strain supernatant-mediated disruption of Caco-2 intestinal epithelial barrier function.
Sutton PA; Li S; Webb J; Solomon K; Brazier J; Mahida YR
Clin Exp Immunol; 2008 Sep; 153(3):439-47. PubMed ID: 18505424
[TBL] [Abstract][Full Text] [Related]
18. The role of toxin A and toxin B in Clostridium difficile infection.
Kuehne SA; Cartman ST; Heap JT; Kelly ML; Cockayne A; Minton NP
Nature; 2010 Oct; 467(7316):711-3. PubMed ID: 20844489
[TBL] [Abstract][Full Text] [Related]
19. Transient expression of RhoA, -B, and -C GTPases in HeLa cells potentiates resistance to Clostridium difficile toxins A and B but not to Clostridium sordellii lethal toxin.
Giry M; Popoff MR; von Eichel-Streiber C; Boquet P
Infect Immun; 1995 Oct; 63(10):4063-71. PubMed ID: 7558320
[TBL] [Abstract][Full Text] [Related]
20. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.
Hirota SA; Iablokov V; Tulk SE; Schenck LP; Becker H; Nguyen J; Al Bashir S; Dingle TC; Laing A; Liu J; Li Y; Bolstad J; Mulvey GL; Armstrong GD; MacNaughton WK; Muruve DA; MacDonald JA; Beck PL
Infect Immun; 2012 Dec; 80(12):4474-84. PubMed ID: 23045481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
